Unlock Proactive Cancer Detection and Care for a Longer, Healthier Life.

How Blood Biomarkers Help Detect Prostate, Colon, and Ovarian Cancer Early

We all know someone—a friend, a family member, a colleague, whose life was changed or even taken by cancer. And what goes in our mind is, 'If only we'd caught it sooner.'

Cancer has changed lives and continues to be one of the leading causes of death in the world. With advanced technology and scientific milestones, we can now find tumors early, monitor cancer treatment, and predict cancer recurrence to live longer, healthier lives. And that’s through cancer biomarkers.

These biological indicators are found in blood, tissues, or other bodily fluids and signal the presence of cancer in the body. Using biomarkers, your doctor can identify cancer at its earliest stages for timely intervention and better health outcomes.

Why Early Cancer Detection Matters

When caught early, cancer becomes more treatable, and you have a significantly higher chance of surviving. Detecting the presence of cancer before it spreads also increases the effectiveness of treatment methods, especially for smaller tumors.

Early cancer screening tests are available to help patients live longer and receive less invasive treatments. These tests also lead to shorter recovery times, so patients can get back to their everyday lives sooner after cancer diagnosis and treatment.

Empowering You at Every Stage

Whether you're concerned about risk, seeking answers, or navigating treatment, Mito Health provides cutting-edge solutions with advanced cancer testing, such as LucenceINSIGHT™ and LucenceINSIGHT™PLUS. These tests can help determine whether someone might have a specific type of cancer and look for possible signs of cancer returning. We also assess your risk factors, including genetics, lifestyle, and medical history, to identify your predisposition to specific cancers.

Why Prostate Cancer Screening Matters

Prostate cancer is one of the most common cancers in men, and early detection drastically improves treatment outcomes. With a simple prostate cancer screening test, including PSA bloodwork and biomarker analysis, we can detect cancer at earlier stages—often before symptoms arise.

• Ask your provider about a blood test to detect prostate cancer
• Learn the importance of tracking your prostate cancer blood levels
• Understand how biomarker screening improves accuracy in prostate cancer diagnosis

Key Biomarkers for Early Cancer Detection

Biomarker testing looks at specific biological markers in your body that can show if cancer is present. Mito Health offers comprehensive and advanced biomarker testing to help you understand your overall health, spot risks for cancer, and take action based on your results to live a healthier life.

• Total Prostate Specific Antigen (PSA): High PSA levels are linked to prostate cancer. This is the most common prostate cancer blood test and is key in early detection and diagnosis.
• Cancer Antigen 125 (CA-125): CA-125 is a marker used in ovarian cancer screening and also assists in carcinomatosis detection.
• Fecal Occult Blood Test: This test detects blood in the stool, an early sign of colorectal cancer and an essential tumor detection method.

Get Your Personalized Longevity Blueprint

Early detection is key to fighting cancer, getting better treatment options, and living a long life. Mito Health’s advanced biomarker testing can help you understand your health and take charge of your well-being.

Join us today and embark on a journey towards a healthier future!